Whats new
Whats new.
Maxim Group - Looking Towards SITC In November; Eftilagimod Abstracts Accepted (Analyst: Jason McCarthy)
October 5th 2022
For a copy of this analyst report please contact your Maxim analyst Jason McCarthy - jmccarthy@maximgrp.com